ROZEX

This brand name is authorized in Austria, Brazil, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug ROZEX contains one active pharmaceutical ingredient (API):

1
UNII 140QMO216E - METRONIDAZOLE
 

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

 
Read more about Methronidazole

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 ROZEX Cream MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D06BX01 Metronidazole D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BX Other chemotherapeutics
Discover more medicines within D06BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 510101401166314
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 20.833-1-02-04
EE Ravimiamet 1012644, 1012655, 1046179, 1046180, 1046191, 1046203, 1046214, 1819234, 1829943
ES Centro de información online de medicamentos de la AEMPS 60536
FI Lääkealan turvallisuus- ja kehittämiskeskus 047317, 088909, 126503, 566040
FR Base de données publique des médicaments 60647323, 67119549, 67763113
GB Medicines & Healthcare Products Regulatory Agency 139633, 146681, 162359, 198608, 28405, 28406, 29236, 29238
HK Department of Health Drug Office 34300
IE Health Products Regulatory Authority 37406, 52357, 58859, 58890, 58991
IL מִשְׂרַד הַבְּרִיאוּת 2910
JP 医薬品医療機器総合機構 2699713Q1026
LT Valstybinė vaistų kontrolės tarnyba 1008622, 1008623, 1008624, 1008625, 1008626, 1068924, 1083923, 1086980, 1090231, 1091523
MT Medicines Authority MA117/00602
NL Z-Index G-Standaard 13832778
NL Z-Index G-Standaard, PRK 33480
NZ Medicines and Medical Devices Safety Authority 5950, 5951
PL Rejestru Produktów Leczniczych 100106296, 100106304, 100163035, 100258103, 100346340, 100350027, 100369771, 100394533, 100423996
SG Health Sciences Authority 08453P, 11198P
ZA Health Products Regulatory Authority 29/13.4.2/0771

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.